Catalent Invests $7.3 Million in Italy

Expands Softgel Encapsulation and Packaging Capabilities in Support of Consumer Health

08-Oct-2018 - Catalent Pharma Solutions announced that it had completed the first phase of a $7.3 million investment to upgrade and expand its packaging and softgel encapsulation capabilities at its facility in Aprilia, Italy. The first phase of investment, completed in August 2018, saw the expansion and ...

Catalent Biologics and Valerius Biopharma to Collaborate on Manufacture of Specialty Biosimilars

16-May-2018 - Catalent Pharma Solutions and Valerius Biopharma AG, a Swiss biopharmaceutical company dedicated to providing interchangeable treatment options for high-priced orphan and non-orphan biologics, announced that they are to collaborate on the development and manufacture of Valerius’ biosimilar ...

Mymetics-Led Consortium Awarded €8.4 Million for Development of Thermo Stable and Cold-Chain Independent Vaccines

24-Apr-2015 - Mymetics Corporation announced that its subsidiary Mymetics BV in the Netherlands is leading a consortium that has been selected to receive project grants with a total value of €8.4 million. A total of €5.3 million is funded as part of Horizon 2020, the European Union research and innovation ...

BASF and Catalent join forces to solve bioavailability challenges

10-Apr-2012 - Catalent Pharma Solutions and BASF have entered into a broad collaboration and Open Alliance to provide solutions to overcome bioavailability challenges of new molecular entities with solubility or permeability challenges. The companies aim to combine their expertise to provide pharmaceutical ...

CEVEC and Catalent Pharma Solutions Offer Joint Cell Line Development Service

17-Jun-2011 - CEVEC Pharmaceuticals and Catalent Pharma Solutions announced a joint commercial cell line development service for pharma and biotech customers worldwide. The offering combines the benefits of CEVEC’s human cell line, CAP-Technology, with Catalent’s GPEx® (Gene Product Expression) Technology to ...

Catalent expands capabilities in testing for melamine in food and medicinal products

06-Nov-2009 - At a time when melamine-contamination has received global attention, Catalent Pharma Solutions continues to rapidly develope new FDA guidance-compliant tests for trace amounts of key contaminants in food and medicine. Incidents of melamine contamination in milk products, baby formula, dairy and ...

Endotis Pharma forms a strategic alliance with Catalent Pharma Solutions for the development of synthetic oligosaccharides

02-Nov-2009 - Endotis Pharma announced the formation of a strategic alliance with Catalent Pharma Solutions (a worldwide leader in pharmaceutical technologies and services). The two companies will collaborate exclusively to develop certain oral formulations of small-glyco drugs and are now focusing on the ...

Catalent Scientist Honored with 2008 Jack L. Beal Award

03-Jun-2009 - An article co-authored by Dr. Hans Westenburg, a senior scientist of structural characterization and analysis at Catalent Pharma Solutions in San Diego, has been selected for the Jack L. Beal Award as best paper for 2008 by the American Chemical Society’s (ACS) Journal of Natural Products. The ...